Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Chubb
Cantor Fitzgerald
Harvard Business School
Deloitte
Citi
US Army
McKesson
QuintilesIMS

Generated: July 18, 2018

DrugPatentWatch Database Preview

FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Fosinopril Sodium And Hydrochlorothiazide, and what generic alternatives are available?

Fosinopril Sodium And Hydrochlorothiazide is a drug marketed by Actavis Labs Fl Inc, Aurobindo Pharma, Emcure Pharms Ltd, Invagen Pharms, Mylan, Sandoz, Sun Pharm Inds Ltd, Teva, and Watson Labs. and is included in nine NDAs.

The generic ingredient in FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE is fosinopril sodium; hydrochlorothiazide. There are six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the fosinopril sodium; hydrochlorothiazide profile page.
Summary for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
US Patents:0
Applicants:9
NDAs:9
Suppliers / Packagers: 8
Clinical Trials: 2
Formulation / Manufacturing:see details
DailyMed Link:FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE at DailyMed
Drug patent expirations by year for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
Pharmacology for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
Ingredient-typeThiazides
Drug ClassAngiotensin Converting Enzyme Inhibitor
Thiazide Diuretic
Mechanism of ActionAngiotensin-converting Enzyme Inhibitors
Physiological EffectIncreased Diuresis

US Patents and Regulatory Information for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 076608-001 Dec 3, 2004 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 077144-002 Aug 16, 2005 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Invagen Pharms FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 090228-001 Jul 9, 2009 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 079245-002 Jul 9, 2009 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Cipla
McKesson
Boehringer Ingelheim
QuintilesIMS
Merck
McKinsey
Citi
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
 
Links

Follow DrugPatentWatch: